# A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies

> **NCT01858792** · — · COMPLETED · sponsor: **Human Genome Sciences Inc., a GSK Company** · enrollment: 1 (actual)

## Conditions studied

- Lupus Erythematosus, Discoid

## Interventions

- **DRUG:** Belimumab 1 mg/kg
- **DRUG:** Belimumab 10 mg/kg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01858792
- **Lead sponsor:** Human Genome Sciences Inc., a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2013-05-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01858792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01858792, "A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01858792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*